Long-term bovine hematopoietic engraftment with clone-derived stem cells

Area of Science:

• Reproductive biology
• Stem cell research
• Immunology

Background:

• Somatic cell nuclear transfer (SCNT) is a technique for therapeutic cloning.
• SCNT offers potential for treating degenerative diseases.

Purpose of the Study:

• To assess the potential of cloned hematopoietic stem cells (HSCs) for therapeutic applications.
• To evaluate the long-term engraftment and multilineage potential of cloned HSCs in a large animal model.

Main Methods:

• SCNT was used to generate cloned bovine fetuses from neo(r)-marked somatic cells.
• Cloned fetal liver (FL) HSCs were transplanted into nuclear donor cows.
• Hematopoiesis was monitored using in vitro progenitor and HSC assays over 13-16 months.
• Chimerism was assessed via PCR in various tissues.

Main Results:

• Cloned HSCs achieved multilineage engraftment, with chimerism detected in blood, marrow, lymph nodes, and endothelium.
• Peak chimerism in blood granulocytes reached 9-17%, with lower levels in lymphocyte subsets.
• Circulating progenitors showed high chimerism (up to 60% neo(r+)) and retained fetal characteristics.
• The animal without pre-transplant myelosuppression showed persisting donor cells in multiple tissues, including 0.25% neo(r+) progenitor cells in marrow.
• Fetal HSCs exhibited a 10-fold competition advantage over adult HSCs.

Conclusions:

• SCNT can generate histocompatible HSCs.
• Cloned HSCs are capable of long-term multilineage engraftment in a large animal model.
• This study supports the potential of therapeutic cloning for regenerative medicine applications.